Brief: Qualigen Therapeutics Inc Receives Nasdaq Notice Regarding Delayed Form 10-K Filing
April 21 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. RECEIVES NASDAQ NOTICE
REGARDING
DELAYED FORM 10-K FILING
* QUALIGEN THERAPEUTICS INC - ON APRIL 20 RECEIVED LETTER
FROM
NASDAQ RELATING TO CO'S FAILURE TO TIMELY FILE ANNUAL REPORT ON
FORM 10-K FOR 2022
Source text for Eikon: ID:nGNX3WWmfN
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on FF EAI Robotics Ecosystem
See all newsBrief: Faraday Future Intelligent Electric Says FFR To Operate Robotics Business
Brief: Faraday Future Signs Deal to Transfer Robotics Business to FFR at $200 Mln Valuation
Faraday Future climbs after robotics unit deal, strategic upgrade into robotaxi operator
Brief: Aixcrypto Provides Context On Schedule 14C Filing
NASDAQ RESUMED AT 12:42 PM